title: Oncogenic mutations regulate tumor microenvironment through induction of growth factors and angiogenic mediators.
abstract: Activating mutations in the tyrosine kinase domain of HER2 (ErbB2) have been identified in human cancers. Compared with wild-type HER2, mutant HER2 shows constitutively activate kinase activity and increased oncogenicity. Cells transformed by mutant HER2 are resistant to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and exhibit an attenuated response to the HER2 antibody trastuzumab. We investigated herein pathways through which mutant HER2 alters the extracellular environment, potentially leading to drug resistance and the effect of simultaneously targeting HER2 and the tumor cell microenvironment with a therapeutic intent. Expression of mutant HER2 in mammary epithelial cells activated autocrine transforming growth factor (TGF) beta1 signaling through a mechanism involving Rac1 and c-Jun N-terminal kinase-activating protein 1-dependent transcription. Cells transformed by an activating mutant of H-Ras (G12V) also expressed higher TGF-beta1 level through Rac1 activation. In addition, mutant HER2 induced the EGFR ligands TGF-alpha and amphiregulin at the mRNA and protein levels. Vascular endothelial growth factor, a target of the TGF-beta-Smad transcriptional regulation, was also induced as a result of expression of mutant HER2. Inhibition of TGF-beta signaling with the Alk5 small molecule inhibitor LY2109761 reduced growth and invasiveness of cells expressing mutant HER2. Combined inhibition of intracellular and paracrine effects of mutant HER2 by trastuzumab and the EGFR antibody cetuximab were more efficient than single-agent therapies. These data suggest that mutations in oncogenes such as HER2 and Ras not only alter intracellular signaling but also influence on other components of the tumor microenvironment by inducing several pro-invasive growth factors. In turn, these serve as extracellular targets of novel therapeutic strategies directed at both cancer-driving oncogenes and the modified tumor microenvironment.
authors.affiliation: Division of Tumor Cell Biology, Beckman Research Institute of City of Hope, Duarte, CA, USA. ewang@coh.org
authors.forename: S E
authors.initials: SE
authors.lastname: Wang
authors.forename: Y
authors.initials: Y
authors.lastname: Yu
authors.forename: T L
authors.initials: TL
authors.lastname: Criswell
authors.forename: L M
authors.initials: LM
authors.lastname: Debusk
authors.forename: P C
authors.initials: PC
authors.lastname: Lin
authors.forename: R
authors.initials: R
authors.lastname: Zent
authors.forename: D H
authors.initials: DH
authors.lastname: Johnson
authors.forename: X
authors.initials: X
authors.lastname: Ren
authors.forename: C L
authors.initials: CL
authors.lastname: Arteaga
mesh_terms: D002460:Cell Line; D066246:ErbB Receptors / Q000378:metabolism; D006801:Humans; D048031:JNK Mitogen-Activated Protein Kinases / Q000502:physiology; D009154:Mutation; D009369:Neoplasms / Q000209:etiology / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics / Q000502:physiology*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics / Q000502:physiology*; D015398:Signal Transduction; D018808:Transcription Factor AP-1 / Q000502:physiology; D053773:Transforming Growth Factor beta1 / Q000096:biosynthesis*; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis*; D020830:rac1 GTP-Binding Protein / Q000502:physiology
chemical_list: D066246:ErbB Receptors; D048031:JNK Mitogen-Activated Protein Kinases; D016283:Proto-Oncogene Proteins p21(ras); D018719:Erb-b2 Receptor Tyrosine Kinases; D018808:Transcription Factor AP-1; D053773:Transforming Growth Factor beta1; D042461:Vascular Endothelial Growth Factor A; D020830:rac1 GTP-Binding Protein; C107953:RAC1 protein, human; C508053:ERBB2 protein, human; C501009:HRAS protein, human
references.citation: Nat Cell Biol. 2002 Jul;4(7):487-94
references.pmid: 12105419
references.citation: J Cell Sci. 2002 Aug 1;115(Pt 15):3193-206
references.pmid: 12118074
references.citation: J Biol Chem. 2001 Dec 28;276(52):48679-92
references.pmid: 11606575
references.citation: Front Biosci. 2001 May 01;6:D685-707
references.pmid: 11333208
references.citation: J Biol Chem. 2004 Jun 4;279(23):24505-13
references.pmid: 15044465
references.citation: Cytokine. 2005 Jan 21;29(2):84-91
references.pmid: 15598443
references.citation: Cancer Res. 2005 Mar 1;65(5):1642-6
references.pmid: 15753357
references.citation: Med Sci Monit. 2004 Apr;10(4):RA89-98
references.pmid: 15039660
references.citation: Nat Rev Cancer. 2007 Mar;7(3):169-81
references.pmid: 17318210
references.citation: Oncogene. 1999 Jan 21;18(3):731-8
references.pmid: 9989823
references.citation: Cancer Cell. 2002 Aug;2(2):127-37
references.pmid: 12204533
references.citation: Cancer Res. 2004 Dec 15;64(24):9002-11
references.pmid: 15604265
references.citation: Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1257-62
references.pmid: 14739340
references.citation: Biochem Biophys Res Commun. 1990 Sep 28;171(3):1145-51
references.pmid: 2222434
references.citation: J Biol Chem. 2007 Sep 21;282(38):27713-20
references.pmid: 17656362
references.citation: Mol Cell Biol. 1990 Apr;10(4):1492-7
references.pmid: 2108318
references.citation: Mol Biol Cell. 2001 Jan;12(1):27-36
references.pmid: 11160820
references.citation: EMBO J. 1996 May 15;15(10):2452-67
references.pmid: 8665853
references.citation: Bioorg Med Chem Lett. 2004 Jul 5;14(13):3581-4
references.pmid: 15177479
references.citation: J Biol Chem. 1998 Oct 23;273(43):28238-46
references.pmid: 9774445
references.citation: Oncogene. 2000 Jun 15;19(26):3013-20
references.pmid: 10871853
references.citation: Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37
references.pmid: 11252954
references.citation: Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L525-34
references.pmid: 17631612
references.citation: J Biol Chem. 2000 Feb 25;275(8):5748-53
references.pmid: 10681561
references.citation: Nat Genet. 2001 Oct;29(2):117-29
references.pmid: 11586292
references.citation: Methods. 2003 Jul;30(3):256-68
references.pmid: 12798140
references.citation: Biochemistry. 2005 Feb 22;44(7):2293-304
references.pmid: 15709742
references.citation: Exp Cell Res. 2004 Aug 1;298(1):167-77
references.pmid: 15242771
references.citation: J Am Soc Nephrol. 2000 Nov;11(11):2007-2016
references.pmid: 11053476
references.citation: EMBO J. 2001 Jan 15;20(1-2):128-36
references.pmid: 11226163
references.citation: Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6809-14
references.pmid: 9618494
references.citation: Mol Cell Biol. 2005 Jun;25(11):4703-15
references.pmid: 15899872
references.citation: Cancer Res. 1999 Jan 1;59(1):99-106
references.pmid: 9892193
references.citation: Cancer Res. 2006 Oct 1;66(19):9591-600
references.pmid: 17018616
references.citation: J Biol Chem. 1996 Jul 12;271(28):16567-72
references.pmid: 8663331
references.citation: Cancer Cell. 2006 Jul;10(1):25-38
references.pmid: 16843263
references.citation: Cancer Res. 2001 Dec 15;61(24):8887-95
references.pmid: 11751413
references.citation: EMBO J. 1997 Apr 1;16(7):1647-55
references.pmid: 9130710
references.citation: J Biol Chem. 1994 Sep 9;269(36):22817-22
references.pmid: 8077234
references.citation: J Biol Chem. 1997 Jan 17;272(3):1429-32
references.pmid: 8999807
references.citation: Nat Rev Cancer. 2009 Aug;9(8):537-49
references.pmid: 19629069
references.citation: Mol Cell Biol. 2003 Dec;23(23):8691-703
references.pmid: 14612410
references.citation: Nature. 2004 Sep 30;431(7008):525-6
references.pmid: 15457249
references.citation: Cancer Res. 2000 Oct 15;60(20):5879-86
references.pmid: 11059786
references.citation: Cancer Cell. 2003 Jun;3(6):531-6
references.pmid: 12842082
references.citation: Mol Cancer Ther. 2001 Dec;1(2):85-94
references.pmid: 12467226
references.citation: J Biol Chem. 1999 Mar 26;274(13):8865-74
references.pmid: 10085130
references.citation: Int J Cancer. 1999 May 31;81(5):682-7
references.pmid: 10328216
references.citation: Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8430-5
references.pmid: 12808151
references.citation: Clin Cancer Res. 2006 Jan 1;12(1):57-61
references.pmid: 16397024
references.citation: Mol Cells. 2006 Apr 30;21(2):167-73
references.pmid: 16682809
references.citation: Mol Cell Biol. 2008 Sep;28(18):5605-20
references.pmid: 18625725
references.citation: J Cell Biol. 2002 Jan 21;156(2):299-313
references.pmid: 11790801
references.citation: J Biol Chem. 2001 Oct 19;276(42):38527-35
references.pmid: 11486006
references.citation: Br J Cancer. 1996 Oct;74(7):1074-80
references.pmid: 8855977